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ABSTRACT 
Foundational advances in eicosanoid signaling, the free radical biology of oxygen and nitric oxide and mass 
spectrometry all converged to enable the discovery of nitrated unsaturated fatty acids. Due to the unique 
biochemical characteristics of fatty acid nitroalkenes, these species undergo rapid and reversible Michael 
addition of biological nucleophiles such as cysteine, leading to the post-translational modification of low 
molecular weight and protein thiols. This capability has led to the present understanding that nitro-fatty acid 
reaction with the alkylation-sensitive cysteine proteome leads to physiologically-beneficial alterations in 
transcriptional regulatory protein function, gene expression and in vivo rodent model responses to metabolic 
and inflammatory stress. These findings motivated the preclinical and clinical development of nitro-fatty 




  The discovery of nitro-fatty acids (NO2-FA) was motivated by new insight into the 
biochemistry of nitration reactions and the signaling actions of oxidized fatty acids.  Four main areas of discovery supported the notion that NO2-FA serve as mediators of 
physiological homeostasis and in pure form as pharmacologically-active agents: 
o The reversible reaction of electrophilic nitro-fatty acids with cysteine and the central 
role of this reaction in modulating key signaling and gene expression responses. 
o The identification of conjugated diene-containing fatty acids such as conjugated 
linoleic acid as main substrate for nitration. 
o The digestive and inflammatory formation of NO2-FA in humans and rodents. 
o The protective anti-inflammatory and anti-fibrotic actions of NO2-FA in a wide range of 




Three foundational discoveries helped direct us down the experimental pathway leading 
to the discovery of fatty acid nitroalkene derivatives (nitro-fatty acids, NO2-FA). 
Prostaglandins and leukotrienes were identified as unsaturated fatty acid oxygenation products 
that mediate receptor-dependent regulation of inflammation, metabolism, and vascular function 
(1). Prior to this discovery, fatty acids and complex lipids were typically viewed as sources of 
metabolic energy and structural constituents of membranes, rather than as substrates for 
signaling mediator biosynthesis. At about the same time, seminal discoveries that led to the 
fields of free radical biology and redox signaling were being made.  Specifically, the generation 
of superoxide (O2.-), hydrogen peroxide (H2O2) and other oxygen-derived species was identified 
in microbes, plants, fish and mammals, along with the existence of small molecule and 
enzymatic antioxidant networks that regulate cell levels of these oxidizing species (2). This led 
to the rapid acceptance of “reactive oxygen species” as mediators of xenobiotic toxicity and host 
defense and later, as cell signaling mediators. Finally, the free radical gas nitric oxide (.NO) was 
identified as a product of nitric oxide synthase-catalyzed arginine oxidative deamination and the 
roles of .NO as a mediator of endothelial-dependent vascular relaxation and neurotransmission 
were described (3). With this critical perspective in mind, we discovered that convergent 
reactions of unsaturated fatty acids and reactive species derived from oxygen, nitric oxide and 
nitrite (NO2-) yield a family of chemically-reactive products that mediate pleiotropic metabolic 
and anti-inflammatory signaling actions.  Moreover, synthetic homologs of NO2-FA may have 
pharmacologic utility, as present data indicates oral bioavailability, good pharmacokinetics, 
signaling pathway engagement and a promising safety profile in model systems and humans.  
There were a number of critical steps that had to be taken and pitfalls to overcome in this 
process of discovery: 
1. Overcoming an initial bias that .NO-derived reactive species primarily mediated 
pro-inflammatory and pathogenic oxidation and nitration reactions.   
We had discovered that the toxicity of O2.- and .NO could be transduced by peroxynitrite 
(ONOO-), the product of their radical-radical reaction, and by the product of ONOO- and carbon 
dioxide (CO2) reaction, nitrosoperoxocarbonate (ONOOCO2). These nitrogen oxides can react 
directly or rapidly undergo homolytic scission (as ONOOH) to yield nitrogen dioxide (.NO2), 
hydroxyl radical (.OH) and, in the case of ONOOCO2, carbonate radical (CO3-.)(4-7). We also 
had discovered that the neutrophil-derived heme protein myeloperoxidase (MPO), upon 
degranulation and reaction with H2O2, catalytically consumes .NO and further oxidizes NO2- to 
the nitrating species nitrogen dioxide (.NO2)(8-10).  Because of the facile ability of MPO to 
generate .NO2 during inflammatory responses and the unique ability of MPO to become 
anatomically “locked” in place by high affinity glycosaminoglycan binding, we also discovered a 
strong spatial co-distribution between MPO and nitrated biomolecules (11,12).  More recently, 
we demonstrated that during .NO autooxidation, NO2- directly participates in fatty acid nitration 
reactions at neutral pH via the formation of symmetrical dinitrogen trioxide (ONONO)(13).  
These reactions, all operative in cell and murine models of inflammation and clinical 
observations, support the physiological relevance of these diverse mechanisms of nitro-
oxidative stress (13,14).  
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2. How we overcame bias and preconceived notions.   
In testing the concept that .NO exacerbates oxidative inflammatory responses in more 
biologically-relevant model systems, we evaluated biochemical, cellular and in vivo responses to 
the co-generation of O2.-, H2O2 and .NO.  It was first observed that .NO more potently inhibited 
the oxidation of membranes and plasma lipoproteins than -tocopherol (15,16).  We then 
extended these studies to more biological model systems by showing that elevated rates of .NO 
biosynthesis or the introduction of .NO donors led to protection of pulmonary and vascular cells 
having elevated rates of O2.- and H2O2 generation.  Similarly, rodents inhaling 95% oxygen (thus 
enhancing rates of pulmonary O2.- and H2O2 generation) were protected from pulmonary oxygen 
toxicity by the introduction of 8 ppm.NO, a concentration of inhaled .NO that is within the range 
of that used clinically to treat pulmonary hypertension (17-19).  In these studies, anti-
inflammatory, antioxidant and tissue-protective responses prevailed that were contrary to 
dogma at the time regarding the biochemical effects of .NO during oxidative inflammatory 
reactions (20).   
 
3. New perspective was gained regarding the tissue-protective and anti-inflammatory 
actions of .NO during oxidative-stress.   
The antioxidant actions of .NO were first ascribed to its kinetically rapid reaction with lipid 
peroxyl radicals, thus terminating autocatalytic free radical-mediated chain propagation 
reactions (15,16,21).  It had become apparent that, depending on concentration and the nature 
of the local free radical milieu, the reactions of .NO could promote both pro-inflammatory and 
anti-inflammatory responses.  This was exemplified in a biochemical reaction system where 
rates of .NO introduction and enzymatic O2.- and H2O2 generation were varied inversely (15).  
The continuous variation of the .NO/O2.- ratios showed that when .NO concentrations exceeded 
those of O2.- and consequent ONOO-/ONOOH formation, lipid peroxidation was inhibited. The 
HPLC-MS/MS analysis of the different reaction conditions in this study also gave the first mass 
spectra showing the nitration of unsaturated fatty acids by oxidative inflammatory conditions. 
Further studies of linoleic acid reaction with ONOO-, ∙NO2, NO2+ or NO2-/HONO also revealed 
both linoleate oxidation and nitration products (22,23).  Previously, photochemical air pollution-
related studies of gaseous nitrogen dioxide (∙NO2) reaction with fatty acids and phospholipids 
had also shown the formation of nitration products (24-26).  Prior to appreciating that NO2-FA 
induce cell signaling responses via the PTM of nucleophilic protein targets, additional 
understanding of the chemical reactions that led to unsaturated fatty acid nitration was acquired 
(27-30).  The fact that nitroalkene-containing hydrocarbons, released at high pressure by a 
termite soldier gland, act as a termite chemical warfare armament for establishing turf domain 
also suggested that fatty acid nitroalkenes might have some unique reactivities (31).  
 
4. Nitric oxide and its secondary products were observed to regulate lipid signaling 
by modulating the enzymatically-catalyzed oxygenation of unsaturated fatty acids.   
The small molecular radius, lipophilicity and free radical character of ∙NO all contribute to the 
broad range of actions that both ∙NO and its secondary nitrogen oxides will exert on the 
oxidative generation of bioactive unsaturated fatty acid products.  These effects have been 
extensively reviewed and include the regulation of the gene expression and changes in the 
catalytic activities and oxygenated lipid product profiles of cyclooxygenase-1 and -2, multiple 
lipoxygenases, CYP450s and soluble epoxide hydrolase (32-34).  When catalyzing fatty acid 
oxidation, cyclooxygenase-1 and -2 and lipoxygenases were observed to catalytically consume 
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∙NO and impair downstream cGMP-dependent signaling actions (10,35-37).  Moreover, 
electrophilic NO2-FA species inhibit cyclooxygenase and lipoxygenase catalysis and gene 
expression (38,39).  These observations affirmed to us that there is a very strong and diverse 
array of biochemical linkages between lipid and ∙NO signaling. 
 
5. The organic synthesis of nitro-oleic, nitro-linoleic and nitro-arachidonic acid 
provided the key to unlocking the analytical, biochemical and pharmacological 
characteristics of nitro-fatty acids.  
The characterization of nitration products of unsaturated fatty acids in model system reactions 
prioritized the first NO2-FA to be synthesized. This was first accomplished by a selenium-
catalyzed nitration reaction that gave mixed regioisomers of linoleic and oleic acid nitroalkenes 
(40-42). Later, the synthesis of specific nitro-oleic acid regioisomers by the Henry nitro-aldol 
reaction further facilitated the discovery of the pleiotropic signaling actions of NO2-FA and the 
definition of structure-function relationships in the responses of signaling networks to different 
fatty acid nitroalkene derivatives (43-49).  Moreover, these synthetic approaches allowed the 
synthesis of isotopically-labeled NO2-FA (13C, 15N and 18O), permitting the development of 
HPLC-based isotopic dilution mass spectrometry methods.  Overall, these capabilities and 
reagents were crucial for defining the endogenous generation, tissue levels, metabolism, and 
signaling actions of this new class of mediators (22,43,44,50-54). Nonetheless, some mistakes 
and incorrect assumptions were made in early studies of the structure and concentrations of 
NO2-FA species in biological systems (15,50). These analytical challenges were similar to the 
those faced in other studies of electrophilic fatty acid derivatives, for example 15-deoxy-
prostaglandin J2 (15d-PGJ2), 4-hydroxy-2-nonenal and -unsaturated fatty acid ketone 
derivatives, when trying to establish their endogenous tissue and plasma levels, with net tissue 
concentrations of these species still remaining controversial.  The later development of 
improved sample preparation, chromatographic separations, and more refined mass 
spectrometric analyses improved NO2-FA structural and concentration determinations (51,55-
63).  Also, better understanding of the bond scission mechanisms operative in mass 
spectrometer-based fragmentation studies permitted the definition of NO2-conjugated linoleic 
acid as the principal nitrated fatty acid regioisomer present in cellular models of inflammation, 
and endogenously in both animal models and humans (13,14,55-57,64).  The availability of solid 
analytical approaches and critical reagents for studying lipid nitroalkene pharmacology were 
crucial for obtaining consistent results between investigators and labs focused on defining the 
mechanisms of NO2-FA generation, metabolism and how these species impact cell and organ 
function.  As discussed in the translational chapter of this series, these goals were 
accomplished in parallel with the acquisition of intellectual property protection, studies of NO2-
FA actions in preclinical models of inflammatory and metabolic diseases and the attainment of 
investment for supporting new drug development activities. Importantly, freely sharing reagents, 
standards, analytical expertise and ideas with colleagues was crucial for correcting mistakes, 
improving methods, replicating results and advancing understanding. 
 
6. Critical issues and novel insights regarding the unique nature of NO2-FA as 
endogenous mediators and new drug candidates. 
Do NO2-FA generate ∙NO? We initially viewed that NO2-FA might serve as an endogenous 
reserve of ∙NO that would be formed by metabolic and inflammatory reactions, and that after 
decay or metabolism would subsequently mediate cGMP-dependent vascular relaxation.  To 
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this extent, we and others have documented very low stoichiometric levels of ∙NO release by 
NO2-FA under aqueous conditions (40,44,65-70).  While the mechanism of ∙NO release is still a 
matter of debate (via a modified Nef reaction or a rearrangement to a nitrite ester and N-O bond 
homolysis), these potential reactions are inhibited in membranes and in the presence of plasma 
constituents such as protein and lipoproteins (44,65,70).  Further lines of evidence coming from 
more biologically relevant systems such as rodent model and clinical studies also do not support 
the occurrence of ∙NO-mediated, cGMP-dependent signaling actions of NO2-FA.  For example, 
acute intravenous infusion of low to high concentrations of NO2-FA does not affect blood 
pressure or heart rate in rodents, dogs and humans (71).  Still, there are other biochemical and 
cellular studies that still suggest that fatty acid nitroalkenes yield ∙NO.  We view that additional 
experimental evidence is needed, that must be supported by the reactions of 15N-labeled NO2-
FA and the subsequent detection of 15NO2- and/or∙15NO.  These approaches are important for 
eliminating the confounding effects of adventitious NO2-, contamination and the concomitant 
modulation of cellular or in vivo sources of ∙NO generation.  In the latter regard, NO2-FA a) 
induce endothelial nitric oxide synthase gene expression and catalytic activity and b) promote 
the upregulation of multiple antioxidant mechanisms that will “preserve” ∙NO by limiting its 
oxidative inactivation and the subsequent generation of secondary nitrogen oxides.(72) 
NO2-FA displays a unique pharmacology that is dissimilar from .NO. In the early 2000s, two cell 
biological studies documented non-cGMP-dependent inhibition of platelet and neutrophil 
function by nitro-linoleic acid (73,74). This work significantly transformed our understanding of 
the mechanisms accounting for the potential signaling actions NO2-FA signaling. Both of these 
studies revealed that, in the absence of cytotoxicity, NO2-FA induced novel anti-inflammatory 
signaling actions at very low concentrations.  This data affirmed that there were effects of NO2-
FA on calcium homeostasis and cAMP/adenyl cyclase signaling that occurred in the absence of 
transcriptional responses and reactions that could be attributable to ∙NO/cGMP. 
Michael acceptor properties – a crucial mechanism of action underlying NO2-FA signaling.  The 
cGMP-independent signaling actions of NO2-FA pointed to non-canonical signaling actions 
being defined by the nitroalkene group of NO2-FA.  This functionality confers unique electrophilic 
character to the -carbon of nitro-activated alkenes. The -NO2 substituent is one of the most 
electron-withdrawing moieties in chemistry, thus when bonded to an alkene it promotes a 
kinetically rapid and reversible NO2-FA Michael addition with cysteine (Cys), a reaction that 
induces the post-translational modification (PTM) of proteins and potentially alters target protein 
structure and function (59,75,76).  These biochemical characteristics (kinetically rapid and 
reversible) differentiate NO2-FA from most other endogenous signaling electrophiles such as 
cyclopentanone prostaglandins and aldehydic lipid oxidation products (e.g., 15d-PGJ2 and 4-
hydroxy-2-nonenal).  These non-nitrated lipid electrophiles, while potentially abundant, react 
slowly with nucleophiles, do not readily -eliminate and can form irreversible Schiff’s base 
products.  Unlike fatty acid cyclopentenone and lipid aldehyde derivatives, NO2-FA will not 
accumulate as thiol addition products or promote toxicity at low concentrations.  The irreversible 
reaction of many Michael adducts under biological conditions can be a main cause of cell 
toxicity (77). Current model systems, preclinical pharmacokinetics and toxicology studies and 
Phase 1 safety evaluation in healthy and obese individuals continue to support that NO2-FA 
such as 10-nitro-oleic acid is safe in humans at pharmacologically-active doses.  A single 
exception to this generalization comes from the topical application of NO2-FA in a model of 
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allergic contact dermatitis. While oral and subcutaneous NO2-FA administration inhibits dermal 
responses to hapten-induced inflammation, the topical administration of solvated NO2-FA results 
in a sustained neutrophil-dependent inflammation (78,79). Even though the inflammatory milieu 
of psoriasis in humans actually increases dermal production and levels of NO2-FA, it appears 
that the high local epithelial concentrations that would result from dermal administration of 
solvated NO2-FA induces pro-inflammatory responses. 
NO2-FA detection approaches evolved in response to new understanding of NO2-FA 
electrophilic character and metabolism. HPLC-MS/MS was crucial for resolving and detecting 
fatty acids having NO2 substituents. Early bioanalysis of NO2-FA was occasionally complicated 
by acid-catalyzed nitration occurring by the formation of nitrous acid from the protonation of 
NO2- to nitrous acid (HNO2) during lipid extractions and de-esterification reactions, leading to 
further generation of NO2-FA.  We learned that one could control for this artifact by including 
15NO2- during tissue handling and extractions, with the formation of 15NO2-FA indicating 
unwanted processing-induced nitration.  Upon realizing that these species were electrophilic, 
new strategies were developed for “fishing out” protein-adducted NO2-FA for MS-based 
structural and quantitative analysis.  Three techniques have been particularly revealing. The first 
involves addition of a high concentration of -mercaptoethanol to cell preparations and tissue 
homogenates to force the -elimination of adducted NO2-FA and reaction with excess -
mercaptoethanol, yielding higher molecular weight adducts that would yield a fragment ion of 
m/z 78.  A second approach is the addition of HgCl2 to biological fluid or tissue samples.  Since 
NO2-FA form reversible adducts with thiols, after an “off reaction” (-elimination of NO2-FA from 
a thiol) Hg will react with the free thiol formed by NO2-FA dissociation, resulting in the inhibition 
of subsequent thiol reactions.  Overall, this results in a net increase in detectable “free” NO2-FA 
and still-electrophilic NO2-FA metabolites. The chemistry of this reaction has not been studied in 
depth and direct interactions of Hg with the NO2-FA adduct should not be excluded. Applying 
this approach to healthy human urine, the Hg-induced NO2-FA displacement strategy increases 
detectable “free” NO2-FA levels by 10-20 fold (57).  More recently, the clinical administration of 
15N-labeled nitrite and nitrate has convincingly shown that fatty acid nitration occurs in humans 
during digestion (Fig. 1) (80,81).  This observation in turn motivated the proposal that the 
cardiovascular benefits of a Mediterranean-like diet, rich in both vegetable-derived NO2- and 
NO3- and marine or olive oil-derived unsaturated fatty acids, could be (in part) ascribed to 
increased NO2-FA generation and the downstream elevation of vasoactive and anti-
inflammatory lipid mediators (82). 
In intracellular environments, where the concentration of low molecular weight and protein thiols 
can exceed 15 mM, the concentration of free NO2-FA is expected to be below 1% of total 
available NO2-FA, given the calculated equilibrium constants (83).  This underscores the need 
to identify the specific protein targets of these bioactive electrophilic lipids.  While biotin 
derivatives of the carboxylate of NO2-FA were initially used, these suffer from increased 
bulkiness, the intrinsic problem of esterase cleavage and disruption of potential CoA ester 
formation, potentially impairing detection and altering intracellular distribution and 
pharmacokinetics.  To address this, -terminal azido derivatives of NO2-FA were synthesized 
for click chemistry-based definition of protein targets. Finally, NO2-FA alkylation increases HPLC 
retention times of modified peptides, allowing for more facile target identification and providing 
an alternative mass spectrometry-based approach for target protein determinations (84). 
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NO2-FA reaction with the cysteine proteome regulates protein expression by the electrophile-
responsive genome.  Affinity labeling and mass spectrometry studies have identified susceptible 
NO2-FA protein targets and now focus has been placed on understanding the biochemical and 
cellular consequences of NO2-FA-protein reactions.  Current perspective holds that transient 
post-translational modification (PTM) of hyperreactive protein thiols by NO2-FA modulates 
signaling pathways involved in cell proliferation and inflammatory responses(85). This occurs as 
a result of the alkylation of functionally-significant Cys residues in transcriptional regulatory 
proteins, including the Kelch-like ECH-associated protein-1 (Keap1) regulator of nuclear factor 
(erythroid-derived-2)-like 2 (Nrf2) signaling, the nuclear lipid receptor peroxisome proliferator-
activated receptor  (PPAR), heat shock factor-1 (HSF-1) and NF-B (48,86,87). Of relevance 
to the anti-inflammatory actions of NO2-FA is the potent and multifaceted inhibition of NF-κB-
mediated signaling, as demonstrated in diverse cell and murine models of cancer, metabolic 
syndrome, cardiopulmonary disease and both acute and chronic renal disease (87-90). 
Unbiased gene expression response studies in human vascular endothelial and smooth muscle 
cells affirm the broad and pleiotropic modulation of adaptive cell responses by NO2-FA that 
would be anticipated from the PTM of key transcriptional regulatory proteins (91,92). Functional 
enrichment analysis of differentially expressed genes reveals multiple cellular processes will be 
affected, including cell proliferation, lipid metabolism, antioxidant and inflammatory-related gene 
expression responses.  
NO2-FA esterification in complex lipids. Since the initial demonstration of increased cholesterol 
nitrolinoleate levels in post-prandial human plasma, further advances related to the 
characterization and quantitation of esterified NO2-FA have been scarce (53,61).  These 
analyses are complicated by the instability of NO2-FA in most hydrolysis conditions, ion 
suppression by native complex lipids during direct mass spectrometric analysis and the 
complexity of the different molecular species expected from various esters of NO2-FA in 
phospholipids, glycerides and sterols. Fortunately, recent advances in the detection and 
characterization of esterified NO2-FA have been made. While phospholipid analysis has not yet 
been translated into in vivo measurements, the presence of NO2-FA containing triglycerides has 
been reported in animal models supplemented with NO2-FA (93,94). Of importance, triglycerides 
are an important storage depot and distribution mechanism for remote organ deposition of NO2-
FA. In this regard, the hydrophobic environment of membranes, lipid droplets, and lipoproteins 
abrogates any nitroalkene reactivity with thiols, even those present in small molecules such as -mercaptoethanol, cysteine and glutathione. In addition to these accessibility limitations for 
Michael addition by esterified NO2-FA, current data indicates that NO2-FA also do not add to 
thiolates in organic solvents, supporting that acid-base chemistry for NO2-FAnucleophile 
reactivity. 
7. Conclusions 
The study of interactions between .NO-derived species and lipid peroxidation intermediates 
motivated the discovery of a functionally unique class of endogenous mediators (lipid 
nitroalkenes). The unique biochemical qualities of the electrophilic nitroalkene substituent 
prompted the evaluation of downstream signaling responses, the acquisition of better 
understanding of the pharmacokinetics and potential toxicity of orally and intravenously-
administered NO2-FA and the in vivo testing of NO2-FA pharmacology in preclinical models of 
metabolic and inflammatory disease.  Moreover, the detection of fatty acid nitroalkenes in plants 
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and their linkage with plant stress responses expands the scope of actions of this class of 
mediators.  These data, reinforced by the observation that NO2-FA are endogenously-generated 
during digestion, inflammatory responses and metabolic stress, has motivated their evaluation 
as therapeutic agents for treating pathogenic cell proliferation, metabolic and inflammatory-
related diseases in humans.  
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Figure 1.  Fatty acid nitration is induced by nitrite and nitric oxide dependent 
mechanisms.  The concentrations of nitrogen oxide precursors for nitrogen dioxide 
generation and levels of readily-nitrated unsaturated fatty acids such as conjugated 
linoleic acid will impact rates of formation and tissue concentrations of fatty acid 
nitroalkene derivatives. 
